What are the benefits of Testosterone Replacement Therapy (TRT) for men with hypogonadism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benefits of Testosterone Replacement Therapy in Men with Hypogonadism

Testosterone replacement therapy (TRT) provides significant benefits for men with hypogonadism, primarily improving sexual functioning and quality of life, while also offering improvements in bone density, muscle mass, and body composition.

Primary Benefits of TRT

Sexual Function

  • TRT significantly improves sexual function in hypogonadal men 1
  • Benefits include increased libido and improved erectile function
  • Sexual dysfunction is one of the most bothersome symptoms for men seeking TRT (66.3% reported erectile dysfunction as their primary concern) 1
  • In men with major depression, TRT improved sexual function even when it didn't affect depression symptoms 1

Quality of Life

  • TRT improves overall quality of life measures in hypogonadal men 1
  • Specific improvements noted in:
    • Vitality
    • Social functioning
    • Mental health composite scores
    • Sense of well-being 1
  • These improvements, while statistically significant, tend to be small to moderate in magnitude 1

Body Composition

  • TRT provides beneficial effects on body composition 1
  • Increases lean muscle mass
  • Reduces fat mass
  • These changes may be particularly beneficial for men with metabolic syndrome 1

Bone Health

  • TRT improves bone mineral density in hypogonadal men 1
  • Helps prevent osteoporosis
  • May reduce risk of fractures, though direct evidence on fracture reduction is limited 1

Metabolic Parameters

  • TRT may improve insulin sensitivity, particularly in men with metabolic syndrome 1
  • May have beneficial effects on glucose metabolism in men with type 2 diabetes, though evidence remains inconclusive 1

Patient Selection and Considerations

Strongest Candidates for TRT

  • Men with documented low testosterone levels AND symptoms of hypogonadism 1
  • Men with primary concerns about sexual function and quality of life 1
  • Men with decreased energy, strength, and endurance 1

Monitoring Requirements

  • Regular monitoring is essential for all patients on TRT 2
  • Key parameters to monitor:
    • Hematocrit (risk of polycythemia)
    • Liver function
    • Lipid parameters
    • Prostate-specific antigen (PSA) 2

Treatment Considerations

Formulation Options

  • Injectable testosterone: Lower cost, higher peak levels, but "roller coaster" effect 1
  • Transdermal gels: More stable levels, easier application, better compliance, but higher cost 1
  • Patient preference plays an important role in selection 1

Duration of Benefits

  • Most studies show benefits within 6-12 months of treatment 1
  • Long-term efficacy and safety data beyond 1 year are limited 1

Important Caveats

  • Benefits on cognitive function appear minimal or absent 1
  • Effects on depressive symptoms are modest and primarily in men without clinical depression 1
  • TRT should not be used primarily for energy improvement, as effects are small 1
  • TRT is not appropriate for all men with low testosterone:
    • Men desiring fertility should consider alternative treatments 3
    • Men with high cardiovascular risk, polycythemia, or prostate cancer risk require careful consideration 3

Conclusion

TRT offers meaningful benefits for hypogonadal men, particularly in improving sexual function and quality of life. While other benefits exist in areas like body composition and bone health, these are generally of smaller magnitude. Proper patient selection, monitoring, and formulation choice are essential to maximize benefits while minimizing risks.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Testosterone replacement therapy in male hypogonadism.

Journal of endocrinological investigation, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.